Malignant solid neoplasm Trials in Houston, United States
Conditions / Malignant solid neoplasm / Houston, United States
Malignant solid neoplasm is a medical condition with active clinical research programs worldwide.
83 total trials for this combination
Showing top 10 of 83 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05554367 | Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial | ACTIVE_NOT_RECRUITING | — |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer | RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT05103358 | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection | RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |